Related Experiment Video

Updated: May 16, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Genetically engineered fusion proteins for treatment of cancer

Ulrich H Weidle1, Britta Schneider, Guy Georges

  • 1Roche Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, Im Nonnenwald 2, D-82372 Penzberg, Germany. ulrich.weidle@roche.com

Cancer Genomics & Proteomics
|November 20, 2012
PubMed

Insights

Genetically engineered fusion proteins offer novel cancer treatment strategies by acting as decoy receptors or immune cell recruiters. These engineered proteins target tumor growth and angiogenesis, showing promise in immunotherapy.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Background:

  • Cancer growth and angiogenesis are complex processes often driven by specific growth factors.
  • Current cancer therapies face challenges in specificity and efficacy.
  • Genetically engineered fusion proteins represent a promising area of therapeutic development.

Purpose of the Study:

  • To review current strategies for treating cancer using genetically engineered fusion proteins.
  • To highlight the dual role of fusion proteins as decoy receptors and immune cell recruiters.
  • To discuss specific examples and future directions in fusion protein-based cancer therapy.

Main Methods:

  • Review of existing literature on fusion protein applications in cancer treatment.
  • Analysis of fusion protein designs targeting growth factor receptors and angiogenesis.
  • Examination of strategies for recruiting immune effector cells to tumors using engineered proteins.

Main Results:

  • Fusion proteins can effectively interfere with growth factor-mediated tumor growth and angiogenesis.
  • Engineered proteins incorporating receptor extracellular domains and Fc regions show therapeutic potential.
  • Strategies for immune cell recruitment include antibody-cytokine fusions and T-cell receptor-based constructs.

Conclusions:

  • Genetically engineered fusion proteins offer versatile approaches for cancer treatment.
  • These proteins can modulate tumor microenvironments and enhance anti-tumor immunity.
  • Further research into fusion protein design and application holds significant promise for oncology.

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...